news

Sanctions bear down on Russian pharma

Russia's pharmaceutical industry is facing a tough new reality. Patients and activists are raising concerns about rising prices and supply disruptions due to Western sanctions. That's as Moscow looks to become self-sufficient in the medical sector with an ambitious nationwide programme. Daniel Hawkins looks at how Russia is coping with the challenge, and what the future holds for its healthcare.

Route 6